ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,712.69
      -0.28%
      US Tech 100
      19,515.20
      0.38%
      Dow Jones
      41,794.60
      -0.61%
      Brent Oil
      75.345
      0.31%
      Bitcoin
      68,813.95
      1.47%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Sagiment Biosciences Inc (SGMT)

      7. Sagiment Biosciences Inc (SGMT) Financials

      Sagiment Biosciences Inc

      Sagiment Biosciences Inc (SGMT)

      NASDAQ
      5.42
      0.09
      (1.69%)
      Closed November 04 4:00PM
      Delayed by 15 minutes
      5.42
      0.00
      ( 0.00% )
      Pre Market: 4:00AM
      Delayed by 15 minutes

      Sagiment Biosciences Inc Financial Summary

      The current SGMT market cap is 166.26M. The company's latest EPS is USD -0.9088 and P/E is -5.96.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)
      Total Revenue 02M000
      Operating Income -7.06M-7.45M-9.47M-8.77M-10.59M
      Net Income -6.79M-6.35M-8.15M-6.63M-8.12M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Total Revenue 002M
      Operating Income -23.72M-31.06M-30.74M
      Net Income -24.44M-30.5M-27.88M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)
      Total Assets 21.5M102.93M96.72M194.53M189.02M
      Total Liabilities 5.29M5.05M5.65M4.51M5.73M
      Total Equity -198.41M97.88M91.07M190.02M183.29M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Total Assets 59.03M33.03M96.72M
      Total Liabilities 2.67M5.36M5.65M
      Total Equity -158.26M-186.95M91.07M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)
      Operating -12.8M-16.68M-23.77M-6.21M-11.84M
      Investing 32.2M32.2M12.58M3M-72.16M
      Financing -1.05M86.17M86.17M104.85M104.82M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Operating -21.71M-24.49M-23.77M
      Investing N/A -32.01M12.58M
      Financing 9.74M-73k86.17M

      Stats and Ratios

      Market Cap 166.26M
      Price to Earnings Ratio -5.96
      Price to Sales Ratio 83.13
      Price to Cash Ratio 2.21
      Price to Book Ratio 1.83
      Dividend Yield -

      Share Statistics

      Shares Outstanding 30.67M
      Average Volume (1 week) 873.82k
      Average Volume (1 Month) 853.63k
      52 Week Change 31.23%
      52 Week High 20.71
      52 Week Low 2.13
      Spread (Intraday) 2.85 (48.39%)

      Company Info

      Company Name Sagiment Biosciences Inc
      Address 2140 south dupont highway
      camden, delaware 19934
      Website https://www.sagimet.com
      Industry pharmaceutical preparations (2834)